Loading
VB15010 is a small-molecule inhibitor from Zhejiang Yangli Pharmaceutical Technology Co., Ltd., in registered phase 2 trials for ovarian cancer, prostate cancer, pancreatic ductal adenocarcinoma.
VB15010 is listed on ClinicalTrials.gov as an intervention in 1 registered phase 2 trial sponsored by Zhejiang Yangli Pharmaceutical Technology Co., Ltd., in ovarian cancer, prostate cancer, pancreatic ductal adenocarcinoma, biliary tract cancer, colorectal cancer. Described in the registry record as a oral parp1 inhibitor; the trial entries below carry the sponsor's wording. OnCo records the agent from the registry alone; approvals, results and the sponsor's own description will follow as they are published.
Described in the registry record as a oral parp1 inhibitor; the trial entries below carry the sponsor's wording.
1.VB15010 slips into a pocket on its target.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"VB15010" OR ABSTRACT:"VB15010") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about VB15010, not a curated reading list.
Shares Ovarian cancer, Pancreatic ductal adenocarcinoma, Prostate cancer and the tags pipeline, registry-only.
Shares Pancreatic ductal adenocarcinoma, Colorectal cancer and the tags pipeline, registry-only.
Shares Ovarian cancer, Pancreatic ductal adenocarcinoma, Prostate cancer, Colorectal cancer and the tag pipeline.
Shares Pancreatic ductal adenocarcinoma, Colorectal cancer and the tags pipeline, registry-only.
Shares Ovarian cancer, Prostate cancer and the tags pipeline, registry-only.
Shares Ovarian cancer, Pancreatic ductal adenocarcinoma, Prostate cancer and the tag pipeline.
Shares Ovarian cancer and the tags pipeline, registry-only.
Shares Ovarian cancer and the tags pipeline, registry-only.